Diabetes remission and relapse after metabolic surgery

Metabolic surgery is an effective treatment option for obese patients with type 2 diabetes mellitus (T2DM). Frequent relapses and significantly decreased remission rates have been started after 10 and 15 years in surgically treated patients. Further concern should be warranted on predictors related...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiaoping, Kong, Xiaomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215947/
https://www.ncbi.nlm.nih.gov/pubmed/29870156
http://dx.doi.org/10.1111/jdi.12871
_version_ 1783368242162565120
author Chen, Xiaoping
Kong, Xiaomu
author_facet Chen, Xiaoping
Kong, Xiaomu
author_sort Chen, Xiaoping
collection PubMed
description Metabolic surgery is an effective treatment option for obese patients with type 2 diabetes mellitus (T2DM). Frequent relapses and significantly decreased remission rates have been started after 10 and 15 years in surgically treated patients. Further concern should be warranted on predictors related to gastrointestinal hormones and metabolic profile of long‐term remission and relapse of T2DM following metabolic surgery in obese patients. [Image: see text]
format Online
Article
Text
id pubmed-6215947
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-62159472018-11-08 Diabetes remission and relapse after metabolic surgery Chen, Xiaoping Kong, Xiaomu J Diabetes Investig Editorial Metabolic surgery is an effective treatment option for obese patients with type 2 diabetes mellitus (T2DM). Frequent relapses and significantly decreased remission rates have been started after 10 and 15 years in surgically treated patients. Further concern should be warranted on predictors related to gastrointestinal hormones and metabolic profile of long‐term remission and relapse of T2DM following metabolic surgery in obese patients. [Image: see text] John Wiley and Sons Inc. 2018-07-09 2018-11 /pmc/articles/PMC6215947/ /pubmed/29870156 http://dx.doi.org/10.1111/jdi.12871 Text en © 2018 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Editorial
Chen, Xiaoping
Kong, Xiaomu
Diabetes remission and relapse after metabolic surgery
title Diabetes remission and relapse after metabolic surgery
title_full Diabetes remission and relapse after metabolic surgery
title_fullStr Diabetes remission and relapse after metabolic surgery
title_full_unstemmed Diabetes remission and relapse after metabolic surgery
title_short Diabetes remission and relapse after metabolic surgery
title_sort diabetes remission and relapse after metabolic surgery
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215947/
https://www.ncbi.nlm.nih.gov/pubmed/29870156
http://dx.doi.org/10.1111/jdi.12871
work_keys_str_mv AT chenxiaoping diabetesremissionandrelapseaftermetabolicsurgery
AT kongxiaomu diabetesremissionandrelapseaftermetabolicsurgery

Ejemplares similares